麦克马斯特大学开发可穿戴贴片可连续监测术后沉默性心脏损伤
Wearable patch could help detect silent heart injury after surgery
麦克马斯特大学团队开发出一种可穿戴贴片,可通过微小聚合物针采集皮下间质液中的心肌肌钙蛋白,实现对非心脏手术后沉默性心肌损伤的连续监测。研究发现约20%高风险患者在非心脏手术后会出现MINS(心肌梗死后的隐匿性心肌损伤),其中约90%无明显症状,传统诊断依赖静脉抽血,居家期间难以完成。
原文明确给出无痛微针采集成人间质液的可行性与小鼠体内测试结果,读者可据此判断该技术的临床转化路径。
Researchers at McMaster University have developed a wearable device that could help detect silent heart injury in the days after surgery, offering a new way to monitor patients after they leave the hospital.
The technology continuously measures cardiac troponin, a protein released when the heart is injured, using a patch equipped with tiny, painless microneedles that sample fluid beneath the skin. The findings were published in the journal Science Advances.
Heart injuries that go unnoticed
The work addresses a significant challenge in postsurgical care. About 300 million people undergo noncardiac surgery each year, and increasing numbers of people are discharged home the same day.
But the days immediately following surgery remain a period of elevated risk, with about 20% of higher-risk patients experiencing myocardial injury after noncardiac surgery, or MINS. Most of these cases occur without obvious symptoms.
"About 90% of these cases are silent. The only way to diagnose many of them is through a blood test, which is difficult when patients are already home," explains Leyla Soleymani, professor of engineering physics and lead of engineering innovation at NexusHealth.
"We wanted to develop a way to continuously monitor for heart injuries without requiring repeated blood draws."
Tracking tiny amounts of troponin
The wearable device uses microscopic polymer needles that penetrate just beneath the skin, without reaching nerves or blood vessels. The microneedles collect interstitial fluid, the liquid that surrounds cells, and deliver it to a biosensor that's able to continuously track cardiac troponin levels over several days.
While continuous monitoring technology already exists for biomarkers such as glucose, proteins are much harder to track continuously. Cardiac troponin is present at very low concentrations in the bloodstream and becomes even more diluted in the fluid beneath the skin.
"That's what makes this such an important advance. We're monitoring a protein that's present at very low levels and doing it continuously in living tissue," she says.
This device builds on previous work by Soleymani and the team in biosensing and aptamer engineering. Aptamers are short strands of DNA or RNA engineered to recognize specific biological targets.
Earlier versions of the technology monitored smaller molecules such as lactate. To detect proteins, researchers combined antibodies, which recognize proteins, and aptamers, which generate a measurable signal. The resulting sensor can continuously track biomarker levels over several days.
"A lot of different pieces had to come together for this work. We had to develop new sensing strategies, create a way to continuously refresh the sensor and integrate everything into a device patients could comfortably wear," says Soleymani.
From microneedles to testing in mice
The project brought together expertise from multiple institutions and disciplines. Researchers at the University of Waterloo developed the microneedle technology that made continuous sampling possible.
"Creating microneedles that can sample interstitial fluid comfortably and painlessly over extended periods and integrating them with sensing electrodes were key steps toward continuous wearable sensing," says coauthor Mahla Poudineh, now an associate professor at the NYU Tandon School of Engineering, whose group pioneered the use of these polymeric microneedles for wearable sensing.
At McMaster, coauthor Bernardo Trigatti, professor in the Department of Biochemistry and Biomedical Sciences and senior scientist in the Thrombosis and Atherosclerosis Research Institute of Hamilton Health Sciences and McMaster University, helped test the technology in living systems, an important step in demonstrating its potential for future clinical use.
"Testing the device in mouse models of heart disease was an important step toward understanding how it could eventually perform in clinical settings," he says.
The work builds on McMaster's internationally recognized leadership in myocardial injury after noncardiac surgery, helping lay the foundation for technologies designed to identify patients at risk and enable earlier intervention.
Further testing and broader ambitions
The research team plans to advance the technology through additional testing. Researchers are also pursuing commercialization through Aptec Health, a startup founded to help bring the technology to patients.
While the immediate focus is postsurgical monitoring, the researchers see much broader possibilities across medicine. Many of the most important health changes happen between clinic visits, and technologies like this could provide a more continuous picture of what's happening in between appointments.
"The future of medicine is personalized, and personalized medicine needs data," says Soleymani.
For her, the project reflects the type of research that motivates her most: tackling difficult scientific challenges that could make a meaningful difference in people's lives.
"I like working on hard problems, and I like working on meaningful problems. This one has both."
Publication details
Hanjia Zheng et al., Beyond Metabolites: A Wearable Biointerface Integrating Antibody and Aptamer Probes for the Real-Time Tracking of Proteins In Vivo, Science Advances (2026). DOI: 10.1126/sciadv.aej0899. www.science.org/doi/10.1126/sciadv.aej0899
Journal information: Science Advances
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Wearable patch could help detect silent heart injury after surgery (2026, November 18) retrieved 18 November 2026 from https://medicalxpress.com/news/2026-11-wearable-patch-silent-heart-injury.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com